Impact of GLP-1A Treatment on Eating Disorder Incidence: A Comparative, Real World Data Study in Patients With and Without Pre-existing Mental Health Conditions
Belly fat, specifically visceral fat that wraps around internal organs, is one of the most dangerous forms of excess weight, linked to increased risk of heart disease, type 2 diabetes, and metabolic syndrome
At Regain, we recognize the hard work that you put in to prioritize your health and wellbeing
Abstract Purpose This retrospective cohort study aims to compare outcomes of Roux-en-Y gastric bypass (RYGB) versus semaglutide for treatment of recurrent weight gain (RWG) and suboptimal weight loss (SWL) after sleeve gastrectomy (SG)
Hui, H., Farilla, L., Merkel, P